Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Anti-androgens can help manage some PCOS symptoms better than metformin but are not more effective than placebos or birth control pills for other symptoms.

Wound healing can help prevent hair loss from chemotherapy in young rats by increasing interleukin-1β signaling.

Beetroot extract nanogel may help treat hair loss caused by testosterone.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

New treatments and technologies in laser medicine show promise for improving skin conditions, fat reduction, cancer treatment, wound healing, and hair restoration.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Medications for glucose metabolism and weight control, combined therapy options, and herbal medicines may help regulate menstrual cycle in adolescents with PCOS.

Birth control pills can help reduce mild to moderate acne in women.

Adult female acne is complex and requires a combination of treatments for effective management.

Many women experience significant hair loss during menopause, and topical minoxidil is an effective treatment.

Androgens play a key role in hair growth and disorders like baldness and excessive hairiness.

Hormonal therapies are safe and effective for treating adult women's acne.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Androgens can both increase body hair and cause scalp hair loss.

Low level laser therapy works best for hair loss, followed by PRP, finasteride, and minoxidil.

Lifestyle changes like diet and exercise are crucial for managing PCOS.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Some birth control pills can cause hair loss, and switching to ones with less androgen should help.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Scalp psoriasis in China mostly affects young adults, worsens with stress, and significantly impacts quality of life.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.